IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 63 filers reported holding IGM BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,350 | -4.7% | 1,361 | +33.0% | 0.00% | – |
Q1 2024 | $9,816 | -25.7% | 1,023 | -35.6% | 0.00% | – |
Q4 2023 | $13,204 | -88.9% | 1,588 | -88.8% | 0.00% | – |
Q3 2023 | $118,763 | +12.0% | 14,223 | +23.8% | 0.00% | – |
Q2 2023 | $106,062 | +82.1% | 11,491 | +171.1% | 0.00% | – |
Q1 2023 | $58,230 | -15.4% | 4,238 | +4.7% | 0.00% | – |
Q4 2022 | $68,857 | -17.0% | 4,048 | +10.9% | 0.00% | – |
Q3 2022 | $83,000 | +43.1% | 3,649 | +13.5% | 0.00% | – |
Q2 2022 | $58,000 | -23.7% | 3,214 | +12.9% | 0.00% | – |
Q1 2022 | $76,000 | -9.5% | 2,847 | 0.0% | 0.00% | – |
Q4 2021 | $84,000 | -54.8% | 2,847 | 0.0% | 0.00% | – |
Q3 2021 | $186,000 | +66.1% | 2,847 | +113.1% | 0.00% | – |
Q2 2021 | $112,000 | +27.3% | 1,336 | +16.4% | 0.00% | – |
Q1 2021 | $88,000 | -12.0% | 1,148 | +1.1% | 0.00% | – |
Q4 2020 | $100,000 | +14.9% | 1,136 | -3.4% | 0.00% | – |
Q3 2020 | $87,000 | -20.2% | 1,176 | -20.6% | 0.00% | – |
Q2 2020 | $109,000 | +153.5% | 1,482 | +85.0% | 0.00% | – |
Q1 2020 | $43,000 | +16.2% | 801 | -18.5% | 0.00% | – |
Q4 2019 | $37,000 | – | 983 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,425,455 | $252,833,000 | 4.64% |
Ikarian Capital, LLC | 313,300 | $23,124,000 | 1.67% |
Ikarian Capital, LLC | 250,000 | $18,452,000 | 1.34% |
RA Capital Management | 982,723 | $72,535,000 | 1.33% |
Artal Group S.A. | 688,910 | $50,848,000 | 1.23% |
Baker Brothers Advisors | 3,144,446 | $232,092,000 | 0.93% |
Cormorant Asset Management, LP | 225,000 | $16,607,000 | 0.64% |
MOODY ALDRICH PARTNERS LLC | 37,737 | $2,785,000 | 0.58% |
HighVista Strategies LLC | 9,417 | $695,000 | 0.51% |
Vivo Capital, LLC | 103,480 | $7,638,000 | 0.44% |